[{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"d3f4c001a4da73a8e9e602d6a8d0f2db22823f26a3e6cc6526f2601beefd9978","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":531,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 531\",\"id\":\"n1\",\"kind\":\"course\"}],\"notes\":[\"Normalized the subject label “PHM SCI” to the allowed linked-course subject “PHMSCI.”\"],\"root\":\"n1\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"d3f4c001a4da73a8e9e602d6a8d0f2db22823f26a3e6cc6526f2601beefd9978","section":"search_profile","status":"valid","value_json":"{\"activity_tags\":[],\"assumed_background\":[],\"search_phrases\":[\"Medicinal Chemistry II\",\"drug SAR\",\"antihyperlipidemics\",\"glucocorticoids\",\"enzyme inhibitors\",\"drug design\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Explain basic chemical principles as they apply to drug SAR\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Explain basic chemical principles as they apply to drug SAR\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":1,\"quote\":\"Identify drug classes and origin based in part on drug structures\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Identify drug classes and origin based in part on drug structures\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":4,\"quote\":\"Apply the knowledge of structural modifications to enhance drug delivery via increased solubility, metabolic stability and bioavailability\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Apply knowledge of structural modifications to enhance drug delivery\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"title\",\"quote\":\"MEDICINAL CHEMISTRY II\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"MEDICINAL CHEMISTRY II covers the chemistry of medicinal products including antihyperlipidemics, glucocorticoids, estrogens, progestins, NSAIDs, antitumor agents, and enzyme inhibitors.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Antihyperlipidemics, glucocorticoids, estrogens, progestins, NSAIDs, antitumor agents, and enzyme inhibitors\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Explain basic chemical principles as they apply to drug SAR\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Drug SAR and basic chemical principles\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":3,\"quote\":\"Explain the difficulty of drug design in light of side effects and complexity of possible drug targets\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Drug design challenges regarding side effects and target complexity\"}]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"d3f4c001a4da73a8e9e602d6a8d0f2db22823f26a3e6cc6526f2601beefd9978","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-49752a259f17fab0f49665b3","output_id":"d3f4c001a4da73a8e9e602d6a8d0f2db22823f26a3e6cc6526f2601beefd9978","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"2265b3e5a98b0368b76f7bafb883b03dbaa0ad41f8db6679350aa7ca5c274dc8\",\"course_id\":\"PHMSCI 532\",\"current_instructors\":[{\"instructor_uid\":\"instructor_aefc2c3ee136e080a0de0c3b\",\"message\":\"No course-specific reviews available\",\"name\":\"Jiaoyang Jiang\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[{\"citations\":[{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1244\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1254\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1264\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Spring 2024: 3.62 GPA, 76.8% A/AB (n=95 letter grades); Spring 2025: 3.54 GPA, 73.4% A/AB (n=94 letter grades); Spring 2026: 3.51 GPA, 71.5% A/AB (n=123 letter grades). Includes jointly taught sections.\"}]},{\"instructor_uid\":\"instructor_aec14caea00731a70e9e9219\",\"message\":\"No course-specific reviews available\",\"name\":\"Weiping Tang\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[{\"citations\":[{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1244\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1254\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1264\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Spring 2024: 3.62 GPA, 76.8% A/AB (n=95 letter grades); Spring 2025: 3.54 GPA, 73.4% A/AB (n=94 letter grades); Spring 2026: 3.51 GPA, 71.5% A/AB (n=123 letter grades). Includes jointly taught sections.\"}]}],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":true,\"profile_hash\":\"3f5110430805ccdd533c0c072df62d68a8a5f5441c4530bbdb15d419a199a09c\",\"quick_take\":[{\"citations\":[{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1244\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1254\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1264\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Spring 2024: 3.62 GPA, 76.8% A/AB (n=95 letter grades); Spring 2025: 3.54 GPA, 73.4% A/AB (n=94 letter grades); Spring 2026: 3.51 GPA, 71.5% A/AB (n=123 letter grades).\"}],\"student_experience\":[],\"task_hash\":\"9dea82ef7f2113a5605c1c6030c4f9b19967eb742cc93a78268fb92357d29f5c\",\"teaching_history\":[{\"citations\":[{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1154\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1164\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1174\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1184\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1194\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1204\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1224\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1234\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1244\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1254\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1264\",\"type\":\"grade\"}],\"text\":\"JIAOYANG JIANG is recorded teaching in Spring 2015, Spring 2016, Spring 2017, Spring 2018, Spring 2019, Spring 2020, Spring 2022, Spring 2023, Spring 2024, Spring 2025, Spring 2026. Recorded history may be incomplete and does not establish a future schedule.\"},{\"citations\":[{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1084\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1094\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1104\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1114\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1124\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1134\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1144\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1154\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1164\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1174\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1184\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1194\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1204\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1224\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1234\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1244\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1254\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20261014T203208-0851c9a1\",\"section_number\":1,\"source_course_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1264\",\"type\":\"grade\"}],\"text\":\"WEIPING TANG is recorded teaching in Spring 2008, Spring 2009, Spring 2010, Spring 2011, Spring 2012, Spring 2013, Spring 2014, Spring 2015, Spring 2016, Spring 2017, Spring 2018, Spring 2019, Spring 2020, Spring 2022, Spring 2023, Spring 2024, Spring 2025, Spring 2026. Recorded history may be incomplete and does not establish a future schedule.\"}],\"term_id\":\"1274\",\"term_name\":\"2027 Sprng\",\"version\":3}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":true},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"2453ae489b67a3fe87c15656dc75bc2e8ebfa1d62655576c041fd87ef141d5b9","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":531,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 531\",\"id\":\"n0\",\"kind\":\"course\"},{\"children\":[],\"condition\":\"Declared in Doctor of Pharmacy program\",\"course\":null,\"evidence\":\"Declared in Doctor of Pharmacy program\",\"id\":\"n1\",\"kind\":\"condition\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"needs_review\"}","error":"Node n1: evidence 'Declared in Doctor of Pharmacy program' must quote an exact source substring.\nUnreachable nodes: n1; connect all conditions and exclusions to the root.","model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"2453ae489b67a3fe87c15656dc75bc2e8ebfa1d62655576c041fd87ef141d5b9","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 531\",\"field\":\"description\",\"quote\":\"Basic concepts in the chemistry of small molecule medicinal products.\"},{\"course_id\":\"PHMSCI 432\",\"field\":\"description\",\"quote\":\"Basic biochemistry as the biochemical basis for drug action.\"}],\"text\":\"Foundational medicinal chemistry and biochemistry principles.\"}],\"search_phrases\":[\"medicinal chemistry drug design\",\"pharmaceutical chemistry antihyperlipidemics\",\"medicinal chemistry enzyme inhibitors\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\"}],\"text\":\"Understanding the chemistry of specific medicinal product classes.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"title\",\"quote\":\"MEDICINAL CHEMISTRY II\"},{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\"}],\"text\":\"MEDICINAL CHEMISTRY II covers the chemistry of various medicinal product classes.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors\"}],\"text\":\"Specific medicinal product classes (antihyperlipidemics, glucocorticoids, etc.)\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"2453ae489b67a3fe87c15656dc75bc2e8ebfa1d62655576c041fd87ef141d5b9","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"fba5cac89d903f09b19d13e01b8755003881a16bacf2157a2dbbe8245c3d2e7e","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":531,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 531\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"fba5cac89d903f09b19d13e01b8755003881a16bacf2157a2dbbe8245c3d2e7e","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 531\",\"field\":\"description\",\"quote\":\"Basic concepts in the chemistry of small molecule medicinal products.\"},{\"course_id\":\"PHMSCI 432\",\"field\":\"description\",\"quote\":\"Basic biochemistry as the biochemical basis for drug action.\"}],\"text\":\"Foundational medicinal chemistry and biochemistry principles.\"}],\"search_phrases\":[\"medicinal chemistry drug design\",\"pharmaceutical chemistry antihyperlipidemics\",\"medicinal chemistry enzyme inhibitors\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\"}],\"text\":\"Understanding the chemistry of specific medicinal product classes.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"title\",\"quote\":\"MEDICINAL CHEMISTRY II\"},{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\"}],\"text\":\"MEDICINAL CHEMISTRY II covers the chemistry of various medicinal product classes.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors\"}],\"text\":\"Specific medicinal product classes (antihyperlipidemics, glucocorticoids, etc.)\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"fba5cac89d903f09b19d13e01b8755003881a16bacf2157a2dbbe8245c3d2e7e","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-6556a505c10f448d98d02466","output_id":"41fa84730949537c9e3a9babd228375eb351cb13c8c1b5c7aa5ea30e468389cb","section":"requirements","status":"invalid","value_json":null,"candidate_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":531,\"minimum_grade\":null,\"subjects\":[\"PHM SCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 531\",\"id\":\"n1\",\"kind\":\"course\"}],\"notes\":[],\"root\":\"n1\",\"status\":\"parsed\"}","error":"Node n1: course {'course_number': 531, 'minimum_grade': None, 'subjects': ['PHM SCI'], 'timing': 'prior'} is absent from the source links (linked_courses). Standing, declared programs, and subject credit counts are condition nodes, not courses. Never invent course 0. For a source reference absent from linked_courses, use kind=condition, course=null, condition=<verbatim source clause>, children=[], and needs_review with an explanatory note. Allowed course references: [{'course_number': 531, 'subjects': ['PHMSCI']}].","model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-6556a505c10f448d98d02466","output_id":"41fa84730949537c9e3a9babd228375eb351cb13c8c1b5c7aa5ea30e468389cb","section":"search_profile","status":"valid","value_json":"{\"activity_tags\":[],\"assumed_background\":[],\"search_phrases\":[\"Medicinal Chemistry II\",\"drug SAR\",\"antihyperlipidemics\",\"glucocorticoids\",\"enzyme inhibitors\",\"drug design\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Explain basic chemical principles as they apply to drug SAR\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Explain basic chemical principles as they apply to drug SAR\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":1,\"quote\":\"Identify drug classes and origin based in part on drug structures\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Identify drug classes and origin based in part on drug structures\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":4,\"quote\":\"Apply the knowledge of structural modifications to enhance drug delivery via increased solubility, metabolic stability and bioavailability\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Apply knowledge of structural modifications to enhance drug delivery\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"title\",\"quote\":\"MEDICINAL CHEMISTRY II\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"MEDICINAL CHEMISTRY II covers the chemistry of medicinal products including antihyperlipidemics, glucocorticoids, estrogens, progestins, NSAIDs, antitumor agents, and enzyme inhibitors.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Antihyperlipidemics, glucocorticoids, estrogens, progestins, NSAIDs, antitumor agents, and enzyme inhibitors\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Explain basic chemical principles as they apply to drug SAR\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Drug SAR and basic chemical principles\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":3,\"quote\":\"Explain the difficulty of drug design in light of side effects and complexity of possible drug targets\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Drug design challenges regarding side effects and target complexity\"}]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-6556a505c10f448d98d02466","output_id":"41fa84730949537c9e3a9babd228375eb351cb13c8c1b5c7aa5ea30e468389cb","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-789789da373eecc1ff75f626","output_id":"2b114927bc1398fed1a7a211b6b5d2ee224e796b3aa8d063e248f0fb6c1010c9","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":531,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 531\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-789789da373eecc1ff75f626","output_id":"2b114927bc1398fed1a7a211b6b5d2ee224e796b3aa8d063e248f0fb6c1010c9","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 531\",\"field\":\"description\",\"quote\":\"Basic concepts in the chemistry of small molecule medicinal products.\"},{\"course_id\":\"PHMSCI 432\",\"field\":\"description\",\"quote\":\"Basic biochemistry as the biochemical basis for drug action.\"}],\"text\":\"Foundational medicinal chemistry and biochemistry principles.\"}],\"search_phrases\":[\"medicinal chemistry drug design\",\"pharmaceutical chemistry antihyperlipidemics\",\"medicinal chemistry enzyme inhibitors\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\"}],\"text\":\"Understanding the chemistry of specific medicinal product classes.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"title\",\"quote\":\"MEDICINAL CHEMISTRY II\"},{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\"}],\"text\":\"MEDICINAL CHEMISTRY II covers the chemistry of various medicinal product classes.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors\"}],\"text\":\"Specific medicinal product classes (antihyperlipidemics, glucocorticoids, etc.)\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-789789da373eecc1ff75f626","output_id":"2b114927bc1398fed1a7a211b6b5d2ee224e796b3aa8d063e248f0fb6c1010c9","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-79348710a077dbb34341f483","output_id":"0acd4fde113ebab05a74378e0c732b6508aad4d3b752e0cc776da58e6f024ad6","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":531,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 531\",\"id\":\"n1\",\"kind\":\"course\"}],\"notes\":[\"Normalized the subject label “PHM SCI” to the allowed linked-course subject “PHMSCI.”\"],\"root\":\"n1\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-79348710a077dbb34341f483","output_id":"0acd4fde113ebab05a74378e0c732b6508aad4d3b752e0cc776da58e6f024ad6","section":"search_profile","status":"valid","value_json":"{\"activity_tags\":[],\"assumed_background\":[],\"search_phrases\":[\"Medicinal Chemistry II\",\"drug SAR\",\"antihyperlipidemics\",\"glucocorticoids\",\"enzyme inhibitors\",\"drug design\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Explain basic chemical principles as they apply to drug SAR\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Explain basic chemical principles as they apply to drug SAR\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":1,\"quote\":\"Identify drug classes and origin based in part on drug structures\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Identify drug classes and origin based in part on drug structures\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":4,\"quote\":\"Apply the knowledge of structural modifications to enhance drug delivery via increased solubility, metabolic stability and bioavailability\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Apply knowledge of structural modifications to enhance drug delivery\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"title\",\"quote\":\"MEDICINAL CHEMISTRY II\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"},{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"MEDICINAL CHEMISTRY II covers the chemistry of medicinal products including antihyperlipidemics, glucocorticoids, estrogens, progestins, NSAIDs, antitumor agents, and enzyme inhibitors.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Antihyperlipidemics, glucocorticoids, estrogens, progestins, NSAIDs, antitumor agents, and enzyme inhibitors\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":0,\"quote\":\"Explain basic chemical principles as they apply to drug SAR\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Drug SAR and basic chemical principles\"},{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"official_learning_outcomes\",\"outcome_index\":3,\"quote\":\"Explain the difficulty of drug design in light of side effects and complexity of possible drug targets\",\"source_url\":\"https://guide.wisc.edu/courses/phm_sci/\"}],\"text\":\"Drug design challenges regarding side effects and target complexity\"}]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20261014T203208-0851c9a1","observed_at":"2026-10-14 17:50:09.728220+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"740d5c4403652f10d29274f87df16fe241bc321dd9369cf1d8c0bcfbbd435215","record_version_id":"c4fbc0523922335a9662bc71b5ccd4c70375a9d0f9f76d3cb767199fae8b1962","job_id":"enrich-79348710a077dbb34341f483","output_id":"0acd4fde113ebab05a74378e0c732b6508aad4d3b752e0cc776da58e6f024ad6","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"Qwen/Qwen3.8-27B","model_revision":"1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"d1d442892213a6f30af3765893c286d0ce2d7d283566d30cbd38ee475335ec9e","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":null,\"course\":{\"course_number\":531,\"minimum_grade\":null,\"subjects\":[\"PHMSCI\"],\"timing\":\"prior\"},\"evidence\":\"PHM SCI 531\",\"id\":\"n0\",\"kind\":\"course\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"d1d442892213a6f30af3765893c286d0ce2d7d283566d30cbd38ee475335ec9e","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 531\",\"field\":\"description\",\"quote\":\"Basic concepts in the chemistry of small molecule medicinal products.\"},{\"course_id\":\"PHMSCI 432\",\"field\":\"description\",\"quote\":\"Basic biochemistry as the biochemical basis for drug action.\"}],\"text\":\"Foundational medicinal chemistry and biochemistry principles.\"}],\"search_phrases\":[\"medicinal chemistry drug design\",\"pharmaceutical chemistry antihyperlipidemics\",\"medicinal chemistry enzyme inhibitors\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\"}],\"text\":\"Understanding the chemistry of specific medicinal product classes.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"title\",\"quote\":\"MEDICINAL CHEMISTRY II\"},{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"Chemistry of medicinal products, including antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors.\"}],\"text\":\"MEDICINAL CHEMISTRY II covers the chemistry of various medicinal product classes.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 532\",\"field\":\"description\",\"quote\":\"antihyperlipidemics, glucocorticoids, estrogens, progestins, nonsteroidal anti-inflammatories, antitumor agents, and enzyme inhibitors\"}],\"text\":\"Specific medicinal product classes (antihyperlipidemics, glucocorticoids, etc.)\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"d1d442892213a6f30af3765893c286d0ce2d7d283566d30cbd38ee475335ec9e","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_29a4d86f540f8538e4b5267f","course_id":"PHMSCI 532","catalog_version_id":"c1d9bb14786814fada2140783d20d21eb5164ba03398bc99852a2adf65ef155d","record_version_id":"a04cae23c18adbe08f6f7a07d5f5953ea7a7cf5b97c66b5de1bb722f3260f4b2","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"d1d442892213a6f30af3765893c286d0ce2d7d283566d30cbd38ee475335ec9e","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"542d7a6eb97cbafc81d2682789a0a2ff5334157eabfd7a54626abeb271330f1b\",\"course_id\":\"PHMSCI 532\",\"current_instructors\":[],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":false,\"profile_hash\":\"5cb4dabf887cdbcd8c00d5a1312e10828b95c63f30bc3ea76aea199565390d02\",\"quick_take\":[{\"citations\":[{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1244\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1254\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 532\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"9dd43b2e-b264-3c12-af4f-d328c2bc82f9\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1264\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Spring 2024: 3.62 GPA, 76.8% A/AB (n=95 letter grades); Spring 2025: 3.54 GPA, 73.4% A/AB (n=94 letter grades); Spring 2026: 3.51 GPA, 71.5% A/AB (n=123 letter grades).\"}],\"student_experience\":[],\"task_hash\":\"74fb0997943e888960bbc9e47db8c4fd12e4292d55c20509d8d89db6a9910f68\",\"teaching_history\":[],\"term_id\":\"1272\",\"term_name\":\"2026 Fall\",\"version\":2}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false}]